Amós García Rojas
Former head of the Epidemiology and Prevention Service of the General Directorate of Public Health of the Canary Islands Health Service, former president of the Spanish Vaccination Association (AEV) and until his retirement in 2024 a member of the WHO Standing Group for Europe
Without a doubt, the Nobel Prize for these two researchers is more than justified for several reasons: firstly, because they have introduced a totally new element in the world of vaccines, such as messenger RNA vaccines, which should lead us to change the historical perception we have of how vaccines intervene in the context of protection against certain transmissible diseases. And also, obviously, because they have provided a rapid and safe response to the major health problem that has arisen in recent times, which has been the SARS-CoV-2 pandemic.
These two elements made it well justified that they should have been awarded the Nobel Prize last year. This was not the case and we all hoped and expected that it would be consolidated in this year's session, and it has been. They are to be congratulated, it is fully deserved and thanks to them the innovation in the world of vaccines that has arisen thanks to their research work means a turning point where nothing will remain the same.